Spero Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $7.4M | $13.8M | $10.3M |
| FY2017 | $8.5M | $93.5M | $87.3M |
| FY2018 | $13.2M | $129.0M | $34.1M |
| FY2019 | $31.5M | $106.1M | $29.7M |
| FY2020 | $21.4M | $153.5M | $85.2M |
| FY2021 | $82.8M | $171.1M | $112.6M |
| FY2022 | $48.9M | $124.8M | $109.1M |
| FY2023 | $75.5M | $182.4M | $76.3M |
| FY2024 | $64.4M | $110.5M | $52.9M |
| FY2025 | $9.9M | $68.9M | $40.3M |